Syndax Pharmaceuticals Inc Income Statement
SNDX / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Syndax Pharmaceuticals Inc reported $172M in revenue and $285M in net loss for FY2025. Revenue has grown at a 75.4% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $172.4M | $23.7M | $0 | $0 | $1.5M | $1.5M | $2.1M | $1.2M | $627.0K | $627.0K | $627.0K | - |
| SG&A Expense | $179.7M | $120.9M | $66.9M | $33.3M | $16.1M | $17.3M | $15.9M | $13.3M | $11.6M | $11.2M | $11.6M | $11.2M |
| R&D Expense | $258.8M | $241.6M | $163.0M | $118.5M | $43.0M | $60.1M | $48.2M | $31.7M | $9.5M | $10.2M | $9.5M | $10.2M |
| Operating Income | -$273.1M | -$339.7M | -$230.0M | -$151.8M | -$57.5M | -$75.9M | -$62.0M | -$43.8M | -$20.5M | -$21.3M | -$20.5M | -$21.3M |
| Interest Expense | - | - | $208.0K | $3.1M | $2.4M | $2.4M | - | - | - | - | - | - |
| Income Tax | $433.0K | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Net Income | -$285.4M | -$318.8M | -$209.4M | -$149.3M | -$56.0M | -$74.0M | -$60.8M | -$44.5M | -$24.1M | -$19.8M | -$24.1M | -$19.8M |
| EPS (Basic) | -$2.98 | -$2.46 | $0.48 | -$1.87 | -$1.84 | - | - | - | - | - | - | - |
| EPS (Diluted) | -$2.98 | -$2.46 | $0.46 | -$1.87 | -$1.84 | -$2.92 | -$2.90 | -$3.22 | -$1519.27 | -$453.02 | - | - |
| Shares Outstanding | 85.7M | 84.8M | 68.1M | 55.0M | 47.9M | 27.1M | 24.8M | 24.4M | 18.2M | 85.4K | 68.4K | 58.2K |
| Operating Margin | -158.4% | -1434.4% | - | - | -3792.9% | -5001.7% | -2939.0% | -3587.4% | -3271.6% | -3402.2% | - | - |
| Profit Margin | -165.6% | -1346.1% | - | - | -3694.6% | -4875.5% | -2884.3% | -3645.3% | -3846.7% | -3162.4% | - | - |